Gastrointestinal Symptom Differential Diagnosis

Diagnostic Evaluation

Clinical discriminators that change pretest probability

• Characterize time course and effect on function: hours versus months, intermittent versus progressive, oral intolerance, stool consistency versus frequency, unintentional weight loss, sleep interruption and objective blood loss.
• Review exposures systematically: NSAIDs, aspirin, anticoagulants, antibiotics, opioids, GLP-1 receptor agonists, supplements, alcohol, travel, food/water, injections, sexual exposure, immunosuppression and prior abdominal surgery.
• Avoid anchoring on a single familiar symptom: GERD does not exclude cardiac ischemia; gallstones found incidentally do not prove the cause of every abdominal complaint; IBS does not explain iron deficiency anemia, persistent bleeding or systemic inflammation.

Differential Diagnosis

Symptom-to-mechanism differential

Presentation	Discriminating features / plausible mechanisms	Next diagnostic priority
Dysphagia	Choking at swallow onset suggests oropharyngeal dysfunction; progressive solids-first suggests narrowing; solids and liquids may indicate motility impairment.	Assess aspiration and weight loss; consider EGD for structural disease; manometry after appropriate structural exclusion.
Heartburn or epigastric pain	Postural regurgitation favors reflux; NSAID or H. pylori exposure raises ulcer risk. Pain pattern alone cannot separate PUD from functional dyspepsia or cardiac disease.	Review bleeding/alarm signs, cardiovascular context and medication exposure; targeted testing/endoscopy when indicated.
Early satiety, persistent vomiting	Gastric retention, ulcer-related obstruction, malignancy, medications or metabolic derangement.	Exclude mechanical obstruction, assess glucose/electrolytes and drug causes; gastric-emptying testing only after exclusions.
RUQ/epigastric pain	Transient postprandial pain: gallstones; persistent pain with fever: cholecystitis; fever, jaundice and systemic illness: cholangitis; pain radiating to back: pancreatitis.	Focused examination, bilirubin/liver tests, lipase and ultrasound; advanced biliary imaging or urgent drainage when warranted.
Bloody or nocturnal diarrhea	Mucosal inflammation: invasive infection, IBD, ischemic colitis, less often malignancy; IBS alone does not explain visible blood.	Hydration, stool testing by exposure, CBC/inflammatory markers, endoscopic evaluation where appropriate.
Chronic watery diarrhea	Fasting-responsive: osmotic; persistent during fasting: secretory; steatorrhea: maldigestion/malabsorption; review medication and bile-acid causes.	Stool phenotype, nutritional/weight changes, targeted labs and stool studies rather than indiscriminate panels.
Lower abdominal pain, altered stool	IBS with recurrent pain linked to defecation; diverticulitis with localized tenderness, fever; obstruction, gynecologic/urinary illness also possible.	Look for fever, peritoneal signs, age/new change, bleeding and weight loss; CT for suspected diverticulitis complications.
Jaundice	Hepatocellular injury, bile-duct obstruction or excess bilirubin production; pruritus/pale stool supports cholestasis, but no symptom is pathognomonic.	Fractionated bilirubin, AST/ALT/ALP, INR and ultrasound as indicated; urgent escalation if infection or encephalopathy.
Constipation or obstipation	Hard stool, straining and outlet symptoms: functional constipation or dyssynergia; acute distension with vomiting: obstruction; leakage: possible impaction.	Evaluate red flags and medications, rectal exam when indicated; urgent imaging for suspected obstruction; targeted evaluation for chronic outlet dysfunction.
Hematemesis, melena or hematochezia	Ulcer/varix/erosion, diverticular bleeding, ischemic colitis or malignancy; brisk upper hemorrhage may cause hematochezia.	Assess hemodynamics, resuscitate, CBC/type-and-cross/coagulation as indicated; urgent endoscopy or localization by clinical source and stability.

Source synthesis: Mills and Ciorba (2019); Mukhtar and Khalili (2019); Rej et al. (2023); Williams and Gordon-Walker (2023).

Constipation: do not miss obstruction or a defecatory disorder

Ask about the baseline bowel pattern, stool form, straining, incomplete evacuation, manual maneuvers, medications (especially opioids and anticholinergics), fluid and mobility changes, surgery, and neurologic or endocrine disease. Acute obstipation with distension, progressive pain and vomiting suggests mechanical obstruction or severe ileus and calls for urgent examination and often imaging, not routine laxatives. Overflow leakage may indicate fecal impaction. Chronic hard stools with recurrent pain linked to defecation suggest IBS-C; marked outlet symptoms raise concern for pelvic-floor dyssynergia. New constipation with bleeding, iron deficiency, weight loss or older-age onset requires reassessment for structural disease (Fortin, 2012; Rej et al., 2023).

GI bleeding: stabilize before attributing a source

Hematemesis strongly suggests an upper-GI source; melena frequently results from upper bleeding but may also arise from proximal small bowel or colon. Hematochezia often indicates lower bleeding yet may occur with brisk upper hemorrhage, especially with shock. Assess airway risk, mental status, hemodynamics, orthostasis, resuscitation needs, CBC, coagulation/renal function, medication-related bleeding risks and type-and-cross before low-yield source testing. Varices, ulcers, erosions, diverticular bleeding, angiodysplasia, ischemic or inflammatory colitis and cancer remain differential considerations. Endoscopy or other localization follows stability and suspected bleeding territory; a single early hemoglobin may not reflect acute loss. Persistent, hemodynamically significant hematochezia can warrant CT angiography to localize active bleeding, whereas stable, subsiding lower-GI bleeding does not always require urgent colonoscopy (Rej et al., 2023; Sengupta et al., 2023; Shergill & McQuaid, 2012).

Diagnostic Limitations and Reassessment

• Interpret testing in context: a normal CRP does not rule out Crohn disease; a negative first transabdominal ultrasound does not exclude every common-duct stone; mild aminotransferase elevation may coexist with advanced fibrosis.

Complications and Red Flags

First determine whether the patient is stable

Urgent evaluation is indicated for shock, significant GI bleeding, peritonitis, suspected bowel ischemia, persistent emesis with severe dehydration, fever with jaundice, or jaundice with confusion/coagulopathy. In cirrhosis, new bleeding, confusion, fever, oliguria or ascites warrants assessment for decompensation and precipitants (Rej et al., 2023; Williams & Gordon-Walker, 2023).

Clinical Reasoning Priorities

Priority scenarios: choose what matters first

Clinical case	Most important competing diagnoses	Immediate next action / reasoning
Adult with crampy bloody diarrhea, tenesmus and weight loss for six weeks.	IBD, infectious dysentery, ischemic/inflammatory colitis; not IBS alone.	Assess stability/anemia, test for infection including C. difficile when indicated, consider colonoscopy with biopsy.
Older adult with RUQ pain, jaundice, fever and reduced blood pressure.	Ascending cholangitis from biliary obstruction versus acute cholecystitis, pancreatitis or hepatocellular injury.	Treat as potential biliary sepsis; cultures, antimicrobials, resuscitation and urgent biliary assessment/source control.
Progressive solids-first dysphagia, unintentional weight loss, regurgitation.	Malignancy or stricture versus achalasia; reflux alone insufficient.	Urgent upper GI evaluation to exclude obstructing lesion before motility-focused workup.
Known cirrhosis with new confusion, melena and creatinine rise.	Bleeding, shock/AKI, infection, encephalopathy, drug effects.	Resuscitate; evaluate GI bleed, glucose, renal function, infection/ascites; do not attribute all findings to ammonia.
New obstipation, severe distension, vomiting and escalating pain.	Mechanical bowel obstruction, severe ileus, ischemia; not routine functional constipation.	Assess shock/peritonitis and electrolytes; urgent cross-sectional imaging and surgical input where indicated.
Hematochezia with hypotension in a patient using anticoagulation.	Brisk upper GI bleed remains possible; diverticular or another lower source also plausible.	Stabilize and type/cross; do not assume stool color proves a distal source; localize after appropriate urgent assessment.

Cases illustrate syndrome prioritization rather than exhaustive testing mandates (Rej et al., 2023; Williams & Gordon-Walker, 2023).

Severe pain and vomiting: triage by physiology

Sudden severe abdominal pain out of proportion to examination in a patient with vascular risk raises concern for mesenteric ischemia and may require urgent vascular imaging. Rigid abdomen, rebound tenderness, free air or sepsis suggests perforation. Bilious vomiting with marked distension or obstipation raises obstruction risk; feculent emesis or escalating pain is especially concerning. In an older or diabetic patient, epigastric pain and vomiting can reflect acute coronary syndrome rather than gastrointestinal disease. Pregnancy testing and pelvic/urinary differentials remain relevant when applicable (Baudendistel & Sandhu, 2012; Rej et al., 2023).

Reasoning errors to avoid

A diagnosis should explain the time course and objective findings. Isolated symptom improvement after acid suppression does not prove peptic ulcer, stool frequency alone does not establish diarrhea, and visible blood or anemia is not an expected feature of uncomplicated IBS. Red flags should be documented and acted on, even when common diagnoses remain possible. Diagnostic plans must also account for age, pregnancy possibility, comorbidity, access to follow-up and the consequences of delayed care (Mills & Ciorba, 2019; Rej et al., 2023).

---

---

References

Baudendistel, T. E., & Sandhu, A. (2012). Abdominal pain. In M. C. Henderson, L. M. Tierney Jr., & G. W. Smetana (Eds.), The patient history: An evidence-based approach to differential diagnosis (2nd ed., Chapter 31). McGraw Hill.

Fortin, A. H., VI. (2012). Constipation. In M. C. Henderson, L. M. Tierney Jr., & G. W. Smetana (Eds.), The patient history: An evidence-based approach to differential diagnosis (2nd ed., Chapter 32). McGraw Hill.

Mills, J. C., & Ciorba, M. A. (2019). Gastrointestinal disease. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., Chapter 13). McGraw-Hill Education.

Mukhtar, N. A., & Khalili, M. (2019). Liver disease. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., Chapter 14). McGraw-Hill Education.

Rej, A., Chew, T. S., & Sanders, D. S. (2023). Gastroenterology. In I. D. Penman, S. H. Ralston, M. W. J. Strachan, & R. P. Hobson (Eds.), Davidson’s principles and practice of medicine (24th ed., pp. 781–858). Elsevier.

Sengupta, N., Feuerstein, J. D., Jairath, V., Shergill, A. K., Strate, L. L., Wong, R. J., & Wan, D. (2023). Management of patients with acute lower gastrointestinal bleeding: An updated ACG guideline. American Journal of Gastroenterology, 118(2), 208–231. https://doi.org/10.14309/ajg.0000000000002130

Shergill, A., & McQuaid, K. R. (2012). Acute gastrointestinal bleeding. In M. C. Henderson, L. M. Tierney Jr., & G. W. Smetana (Eds.), The patient history: An evidence-based approach to differential diagnosis (2nd ed., Chapter 36). McGraw Hill.

Williams, M. J., & Gordon-Walker, T. T. (2023). Hepatology. In I. D. Penman, S. H. Ralston, M. W. J. Strachan, & R. P. Hobson (Eds.), Davidson’s principles and practice of medicine (24th ed., pp. 859–920). Elsevier.